China conditionally approves four self-developed COVID-19 vaccines: official
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- Chinese vice-premier stresses innovation in development
- Top legislator urges NPC deputies to contribute to Chinese modernization
- China launches 504-qubit quantum chip, open to global users
- Chinese vice-premier urges intensified emergency rescue, flood response work
- Chinese Defense Minister holds talks with Kazakhstan president
- China opens 829 sites providing free pneumoconiosis treatment